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Summary
Purpose: The findings of previous studies have been controversial regarding the
optimal surgical procedures required for effective seizure control. In particular,
there are varying views as to whether or not lesionectomy of a temporal-lobe-mass
lesion is a satisfactory process or whether removal of additional seizure foci is
necessary. In this study, we evaluated the efficacy of additional removal of electrically
positive foci using intraoperative electrocorticography on mass lesions related to
temporal lobe epilepsy.
Methods: Thirty-five medically intractable epilepsy patients with temporal-lobe
benign mass lesions, who had been surgically treated, were assessed. The relationship
between resection of the epilepsy focus using intraoperative electrocorticography
and seizure outcome was analyzed. In addition, the sites of residual spikes after lesion
removal were evaluated.
Results: In this study, the benign mass lesions consisted of 21 gangliogliomas, 8
cavernous angiomas and 6 dysembryoplastic neuroepithelial tumors. The number of 3-
year postoperative seizure-free incidences for the group that underwent lesionect-
omy plus additional spike-positive site resection equated to 90.9%. In contrast, in the
group that underwent a lesionectomy only, 76.9% were seizure-free for 3-years
postoperatively. After complete removal of mass lesions, 86.4% of the residual spikes
were detected over the hippocampus.
Conclusion: Even after the complete removal of temporal-lobe-mass lesions, a high
frequency of residual spikes was obtained from the hippocampus. Effective surgical
seizure control was achieved by carrying out additional procedures on the affected
hippocampus. To detect seizure foci surrounding the lesion, especially over the
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hippocampus, intraoperative electrocorticogram monitoring was shown to be an
effective technique.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
It has been postulated that postoperative seizure
outcome is affected by the ‘completeness’ of epi-
leptogenic zone resection. The accurate localiza-
tion of the epileptogenic zone requires careful
electroencephalogram (EEG) assessment, includ-
ing interictal and ictal recordings using a scalp
and/or invasive electrode. However, consensus
on the electrophysiological approach for mass
lesion-related temporal-lobe epilepsy (TLE) has
not been established. The importance of carrying
out resection of the epileptic area next to the
tumor, in terms of seizure outcome, remains
controversial.
The effects of a mass lesion on the surrounding
brain parenchyma include mechanical compression,
increased pressure, ischaemia and specific trophic
factors.1—4 Particularly in the temporal-lobe region,
mass lesions often induce secondary epileptogeni-
city in the mesiotemporal structures.5 This indicates
that surgical procedures applied to the mesiotem-
poral structures are a topic of discussion for mass
lesion-related TLE cases. Penfield and Jasper recom-
mend that the operative procedure should include
removal of the adjacent electrocorticogram (ECoG)
active site, in addition to the tumor, to obtain
optimal seizure control.6 Falconer’s group carried
out a complete temporal lobectomy, including
removal of the mesiotemporal structures, resulting
in excellent seizure control in 80% of their tumor
cases.7,8
On the other hand, satisfactory seizure control
has also been reported for complete lesionec-
tomies in mass lesion-related TLE patients.9,10 In
recognition of the generally favorable outcome of
lesionectomy only, some physicians have suggested
that resection of the surrounding epileptic
area may not provide additional seizure control
that can be achieved with simple, complete
lesionectomy.
To improve seizure outcome, more detailed elec-
trophysiological, histophathological and biochem-
ical knowledge is necessary, and other surgical
and/or medical treatments should be examined.
In this study, we reviewed temporal-lobe benign
mass-lesion-related intractable epilepsy cases,
and studied the efficacy of intraoperative ECoG
monitoring for surgical results.Materials and methods
Patients who were surgically treated for medically
intractable epilepsy caused by temporal-lobe
benign mass lesions at the Department of Neurosur-
gery of the Tokyo Metropolitan Neurological Hospital
from 1989 to 2002 were enrolled in this study.
Thirty-five patients were observed for at least 3
years for their seizure outcome. All patients under-
went a neurological examination, neuropsychiatry
test, magnetic resonance imaging (MRI), computed
tomography (CT) and several sessions of scalp EEG
with a sphenoidal lead prior to surgery. To determine
the seizure semiology, detailed histories were taken
from the patients and their relatives, and contin-
uous video or video-EEG monitoring was performed.
Lesionectomies were performed for all temporal-
lobe lesions. Before 1995, it was not possible to
perform reliable intraoperative ECoG monitoring.
The anesthesia method has now been fine-tuned and
we have been able to obtain reliable intraoperative
ECoG data since 1995. The first 13 cases were
treated by lesionectomy without ECoG monitoring,
and were placed in the non-ECoG group. The
remaining 22 cases were treated by lesionectomy
and additional focus resection based on intraopera-
tive ECoGmonitoring, and placed in the ECoG group.
The surgeries were carried out by a single neuro-
surgeon (second author).The approach to mesial
temporal-lobe structures was through the superior
temporal gyrus corticotomy. The approach to the
temporal-lobe tumor, which locates laterally to the
mesial temporal-lobe structures, was through the
nearest gyrus corticotomy.
Anti-epileptic drugs (AEDs) were discontinued on
the morning of surgery. Anesthesia was induced by
administering 5.0% sevoflurane and 95.0% oxygen
without intravenous narcotic agents, and was main-
tained using 2.5% sevoflurane with an adequate
muscle relaxant. End-tidal CO2 levels were main-
tained at around 30 mmHg during ECoG monitoring.
The lesionectomy was carried out first, and intrao-
perative ECoGs were subsequently recorded over
the hippocampus, the amygdala, the temporal base
area and the lateral surface of the temporal-lobe.
Based on the findings of the ECoGs, additional resec-
tion was carried out on the adjacent epileptic areas.
The findings of the intraoperative ECoGs and the
surgical procedures were reviewed using surgical
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also reviewed using the records and was confirmed
by postoperative MRI. The surgical specimens were
examined by hematoxylin-eosin staining and other
immunohistochemical staining was carried out if
required.
Thepost-surgical seizurefrequencyandcharacter-
istics, scalp EEGs and MRIs were analyzed 1 and 6
months,aswellas1year,aftersurgery.Administration
ofAEDswasdecreasedwheneffective seizure control
was achieved at the 1-year follow-up stage. Some
patients were followed-up at other hospitals, and
telephone interviews were therefore performed.
The seizure outcomes, level of AED intake and tumor
recurrencewere further investigated every year for a
3-year postoperative period. To investigate the effi-
cacy of ECoG monitoring for postoperative seizure
control, we compared the seizure outcome between
the ECoG and non-ECoG groups according to whether
they were seizure-free or not, and we subsequently
carriedoutstatisticalevaluationbychi-squareanalysis
at6months,1year,2yearsand3yearsaftersurgery.AP-
value of less than 0.05 was accepted as indicating
statistical significance.
For the ECoG group, patients were subdivided
based on their tumor locations. Cases with amygdala
but not hippocampus involvement composed oneTable 1 Clinical characteristics
ECoG
Patient profiles
n 22
Age (years) 22.1  12.1
Male/Female 14/8
Right/Left 13/9
Onset (years) 14.2  10.9
Duration (years) 7.9  7.0
Tumor type
Ganglioglioma 13
Cavernous angioma 6
DNT 3
Seizure type [n (%)]
Temporal CPS 22 (100)
Generalized complex seizure 9 (30.0)
Frontal CPS 0 (0)
Absence 1 (3.3)
SPS 1 (3.3)
Infantile spasm 0 (0)
Co-existent pathology [n (%)]
Dual pathology 5 (16.7)
Co-existence 7 (23.3)
Microdysgenesis 3 (10.0)
Tuber 1 (3.3)
Clinical data of 35 intractable epilepsy patients with temporal-lobe
between ECoG and non-ECoG groups. CPS: complex partial seizure, D
seizures.group; cases with amygdala and hippocampus invol-
vement were another group; cases with involvement
of the hippocampus only were another group; and
cases involving the extra-amygdala and hippocam-
pus were the last group. The frequencies of residual
spikes after lesionectomy were evaluated for the
amygdala, hippocampus, temporal base area and
lateral surface of the temporal lobe in each sub-
divided group.
Neuropsychiatry tests were carried out before
and 6 months after the surgery. To investigate their
memory function, especially verbal memory func-
tion, selective reminding procedures using unre-
lated words11 was indicated for the patients who
could complete the task. We evaluated the result as
a percentage of the reminded number of words. The
neuropsychiatry results were compared between
the dominant and non-dominant hemisphere surgery
and also the ECoG and non-ECoG group.Results
Clinical characteristics
The clinical characteristics of the ECoG and non-
ECoG groups are shown in Table 1. The mass lesionsNon-ECoG Total
13 35
20.9  13.9 21.7  12.6
5/8 19/16
7/6 20/15
12.3  11.9 13.5  11.1
8.7  8.0 8.2  7.2
8 21
2 8
3 6
12 (92.3) 34 (97.1)
5 (38.5) 14 (32.6)
1 (7.7) 1 (2.3)
0 (0) 1 (2.3)
0 (0) 1 (2.3)
1 (7.7) 1 (2.3)
5 (38.5) 10 (23.3)
4 (30.8) 11 (25.6)
0 (0) 3 (7.0)
0 (0) 1 (2.3)
lesions. There was no statistical difference for each category
NT: dysembryoplastic neuroepithelial tumor, SPS: simple partial
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Figure 1 Seizure-free occurrences in ECoG and non-
ECoG groups. Seizures recurred as the observation period
increased. The P-value of chi-square analysis between the
ECoG and non-ECoG groups after 1-year postoperatively
was 0.02 (indicated by *).consisted of 21 gangliogliomas, 8 cavernous angio-
mas and 6 dysembryoplastic neuroepithelial tumors
(DNTs). There was no statistical difference for each
category between ECoG and non-ECoG groups.
Complete tumor resection was confirmed in 31
patients, whereas incomplete resection occurred in
three cases of ganglioglioma and in one case of
DNTs. Subsequent MRIs showed that tumor recur-
rence occurred in two patients with ganglioglioma.
The mortality rate was 0%, and the rate of minor
postoperative complications relating to surgery was
3.0%, corresponding to 1 case. This patient showed
transient motor weakness that was confirmed by the
MRI, as being a small cerebral infarction in the basal
ganglia.
Seizure outcome
Seizures recurred as the observation period was
prolonged; however, the seizure outcomes of both
groups did not change 2 years after surgery.
In the ECoG group, the seizure-free occurrences
at 6 months, 1, 2 and 3 years postoperatively were
100, 95.5, 90.9 and 90.9%, respectively. In contrast,
seizure-free occurrences at the same time points for
the non-ECoG group were markedly lower: 92.3,
84.6, 76.9 and 76.9%, respectively. Chi-square ana-
lysis to compare seizure-free with non-seizure-free
occurrences between the ECoG and non-ECoG
groups showed statistical significance after 1 year
(P-value = 0.02; Fig. 1).
Spike analysis from intraoperative ECoG
monitoring
After resecting each lesion, residual spikes were
frequently observed over the hippocampus and
amygdala. Spikes over the hippocampus were con-
firmed to occur in 86.4% (19 out of 22) of cases. Even
in cases in which the lesions did not involve the
hippocampus, residual spikes were frequentlyTable 2 Spike frequency obtained from intraoperative ECo
Location Number Spikes by
Hippocam
Extra-amygdala and hippocampus 7 7
Amygdala 4 2
Amygdala and hippocampus 7 6
Hippocampus 4 4
Total 22 19
High frequency residual spikes were observed over the hippocampus
that involved the hippocampus showed spikes over the residual hipobserved in 81.8% of cases. The amygdala was the
secondmost frequent region in which residual spikes
occurred after lesionectomy, occurring in 63.6%
patients, which corresponds to 14 out of 22 cases
(Table 2).
The frequency of final surgical resection for the
hippocampus and amygdala is shown in Table 3.
Although the frequency of hippocampectomy was
20 out of 22 ECoG-recorded cases, 19 cases needed
additional resection of the hippocampus according
to the intraoperative ECoG findings. This tendency
also applied to the amygdala: 14 cases indicated
additional resection of the electrically positive resi-
dual amygdala.
Neuropsychiatry test
Neuropsychiatry results before and after the sur-
geries are presented in Fig. 2. The task was per-
formed in 9 patients in the non-ECoG group and 15
patients in the ECoG group, respectively. The pre-
operative scores of the verbal memory functionG
intraoperative ECoG
pus Amygdala Temporal-lobe
base
Lateral surface
of temporal lobe
6 2 1
3 1 2
2 3 2
3 2 0
14 8 5
(19 out of 22 cases) and amygdala (14 out of 22 cases). Lesions
pocampus in 10 out of 11 cases (91.0%).
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Table 3 Surgical resection
Location Number Surgical resection based on intraoperative ECoG
Hippocampus Amygdala
Extra-amygdala and hippocampus 7 7 6
Amygdala 4 2 4
Amygdala + hippocampus 7 7 7
Hippocampus 4 4 4
Total 22 20 21
Additional resection of the hippocampus and amygdala was carried out in many cases based on intraoperative ECoG.were higher in the group that had the lesion located
in the non-dominant hemisphere compared with the
group that had the lesion located in the dominant
hemisphere. Within the non-dominant hemisphere
group, post-operative scores improved in four out of
five patients in the non-ECoG group and in four out
of seven patients in the ECoG group.Figure 2 Neuropsychiatry test (selective reminding proced
both the ECoG and non-ECoG group tends to improve after n
memory functions were worsened after dominant hemisphere
group. Circles indicate mesial temporal lobe lesions. Triangles
cases with coexisting hippocampal atrophy.On the contrary, the verbal memory function of
dominant hemisphere tends to deteriorate after the
surgery. This tendency did not differ between the
non-ECoG and ECoG groups. Even the cases that
had coexisting hippocampal atrophy and that had
undergone hippocampal resection worsened the
verbal memory function after the surgery. Onlyures using unrelated words). Verbal memory functions in
on-dominant hemisphere surgery. On the contrary, verbal
surgery in not only the ECoG group but also the non-ECoG
indicate lateral temporal lobe lesions. Dark color indicates
Surgery for lesional temporal-lobe epilepsy using intraoperative electrocorticography 125the patients that had laterally located lesions in the
non-ECoG group maintained the function.Discussion
Establishing the follow-up period for mass lesion-
related TLE is a significant area that deserves
attention. Morris et al. reported that seizure-free
occurrences in patients with ganglioglioma
decreased as the observation period was pro-
longed.12 In our study, seizure-free occurrences
also continued to decrease as the follow-up period
was prolonged. However, the seizure outcomes of
both the ECoG and non-ECoG groups stabilized 2
years after surgery and the ratios were 90.9 and
76.9%, respectively. Consequently, at least 2 years
of follow-up is mandatory and the seizure outcome
at 2 years postoperatively is meaningful for predic-
tion of future results.
For mass lesion-related intractable epilepsy, one
of the surgical goals is the completeness of lesio-
nectomy. Several previous reports noted that com-
plete tumor resection is the most important factor
in not only tumor recurrence, but also in seizure
control.4,5,13—18 However, in some reports, despite
gross complete resection being accomplished for
glio-neural tumors such as gangliogliomas and DNTs,
seizure outcomes have been reported as unsatisfac-
tory, and the number of seizure-free occurrences for
surgically treated gangliogliomas equates to around
60%.7,13,19 In our study, four patients with gang-
lioglioma did not cease having seizures, although
two patients underwent complete tumor resection.
Prayson hypothesized that the cause of unfavorable
seizure outcomes for glio-neural tumors may be
neuronal migration disorder around the neo-
plasm.20,21 From this hypothesis, the lesionectomy
with additional resection of the surrounding cere-
bral tissue without intraoperative ECoG monitoring
seemed to be adequate. The surgical strategy, how-
ever, does not show any electrophysiological evi-
dence for any patient. Further basic studies on
tumorigenesis and neuronal migration are needed
to elucidate the epileptogenic nature of glio-neu-
ronal neoplasms.
Another point of discussion in seizure control is
tumor location. Cascino et al. reported that stereo-
tactic lesionectomy is effective for seizure control
against mass lesion-related epilepsy, although they
also insisted that temporal-lobe lesions are less
likely to be rendered seizure-free by using this kind
of resection only.22 Furthermore, some physicians
have proposed that mass lesion-related epilepsy in
the temporal lobe should be treated in a different
way to mass lesion-related epilepsy arisingfrom other locations, and additional resection of
mesiotemporal-lobe structures after lesionectomy
has improved seizure outcome.7,19,22—27 On the
other hand, other physicians insist that absolute
mesiotemporal-lobe resection does not guarantee
a better prognosis for mass lesion-related TLE sur-
gery.5,28 In this study, lesionectomies only resulted
in a 76.9% seizure-free occurrence, but this was
further improved to 90.9% by additional resection
of the hippocampus and amygdala based on intrao-
perative ECoG monitoring. As about two-thirds of
tumors involved the hippocampus and amygdala,
the targets of additional resection were their resi-
dual parts. Our results provide evidence that intrao-
perative ECoG over the hippocampus and amygdala
can show the requirement and extent of mesiotem-
poral-lobe resection in mass lesion-related TLE sur-
gery. Meaningful additional resections of residual
mesiotemporal-lobe structures can lead to
improved seizure outcome.
From our regional spike analysis, residual spikes
from the hippocampus could be detected in 19 out of
22 patients (86.4%) after simple lesionectomy.
According to the high frequency of these spikes,
we can assume that they could even be detected in
non-ECoG group patients in many cases. Despite
this, the seizure-free occurrence rate reached an
almost acceptable level at 76.9%. In addition, in the
non-ECoG group, the lesions were located in extra-
mesial temporal lobes in 5 out of 13 cases, and 4 out
of these cases ceased their seizure after complete
lesionectomy without resecting the surrounding
brain. Therefore, some residual spikes may not
influence clinical seizures and the running-down
phenomenon may be induced.29 In such circum-
stances, these electrophysiological changes pre-
sumably do not reach the stage of ‘independent
secondary epileptogenicity’, and effective seizure
control may be possible by lesionectomy alone. On
the other hand, residual spikes, inducing clinical
seizures, certainly exist, as so-called true ‘indepen-
dent secondary epileptogenicity’. Strictly speaking,
the treatment of these independent secondary epi-
leptic spikes can improve seizure outcomes. Some
characteristic differences among residual spikes
must exist; however, it is currently unknown what
differences are important for clinical significance.
The analysis of spikes from intraoperative ECoG is
one method of elucidating this difference.
Additional removal of ECoG-positive sites, parti-
cularly the hippocampus and the amygdala, amelio-
rated the seizure outcome. However, we have to
consider the memory function, particularly in cases
that haveECoG-positive sites located in thedominant
hemisphere. In dominant hemisphere surgery, the
postoperative verbal memory function worsened.
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hemisphere surgery was seen in both the ECoG and
non-ECoG group. Memory function in dominant hemi-
sphere surgery influenced not only the additional
removal but also the partial removal of the hippo-
campus. It is better to define the neurological critical
region and seizure origin before the resection, but
the current intraoperative ECoG monitoring is not
suitable for differentiating such sites because the
monitoring is carried out under anesthesia. Other
methods to define the spatial and functional differ-
ences before the resective surgery, or other surgical
procedures topreserve thecognitive function,will be
necessary in the future.
Total lesionectomy is required, as noted in pre-
vious reports, and additional complete treatment of
the epileptic area around the lesion, especially in
the hippocampus and amygdala under the guidance
of ECoG, is effective for benign mass lesion-related
TLE. Cognitive impairment after dominant hemi-
sphere surgery is another future problem that needs
to be elucidated.Conclusions
Even after the complete removal of temporal-lobe-
mass lesions, some spikes remained in the hippo-
campus with high frequency. Effective surgical sei-
zure control was achieved by carrying out additional
procedures on the affected hippocampus. Intrao-
perative ECoG monitoring over the hippocampus
and amygdala is useful for assessing the requirement
and extent of mesiotemporal-lobe resection in mass
lesion-related TLE surgery.
Cognitive function preservation in the case of
dominant hemisphere surgery is another problem.
In the future, we need to find other surgical proce-
dures that cease the residual spikes without cogni-
tive impairment.References
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